Skip to content

The influence of sodium dialysis on blood pressure variability in hemodialysis patient: a randomized controlled trial

The influence of sodium dialysis on blood pressure variability in hemodialysis patient: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17013160
Enrollment
Unknown
Registered
2017-10-26
Start date
2017-11-01
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis

Interventions

treatment group:Using dialysate dialysis, the sodium concentration of dialysate was reduced from 148 mmol/L to 133mmol/L
Control group:Constant sodium concentration (140mmol/L) was used

Sponsors

The Third Affiliated Hospital, Sun Yat-Sen University, Yuedong Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: From October, 2017, we start to enroll hemodialysis patients with hypertension in the blood purification center of yuedong hospital, the third affiliated hospital of sun yat-sen university.;Inclusion criteria: From October, 2017, we start to enroll hemodialysis patients with hypertension in the blood purification center of yuedong hospital, the third affiliated hospital of sun yat-sen university.;Inclusion criteria: From October, 2017, we start to enroll hemodialysis patients with hypertension in the blood purification center of yuedong hospital, the third affiliated hospital of sun yat-sen university.;Inclusion criteria: From October, 2017, we start to enroll hemodialysis patients with hypertension in the blood purification center of yuedong hospital, the third affiliated hospital of sun yat-sen university.;Inclusion criteria: From October, 2017, we start to enroll hemodialysis patients with hypertension in the blood purification center of yuedong hospital, the third affiliated hospital of sun yat-sen university.

Exclusion criteria

Exclusion criteria: (1) patients with cerebrovascular accident; (2) there were obvious symptoms of headache, dizziness, nausea and vomiting before dialysis; (3) the systolic pressure is greater than 200 mmHg patients before hemodialysis; (4) patients with cardiac grade III-IV; (5) irregular heart rhythm.;Exclusion criteria: (1) patients with cerebrovascular accident; (2) there were obvious symptoms of headache, dizziness, nausea and vomiting before dialysis; (3) the systolic pressure is greater than 200 mmHg patients before hemodialysis; (4) patients with cardiac grade III-IV; (5) irregular heart rhythm.;Exclusion criteria: (1) patients with cerebrovascular accident; (2) there were obvious symptoms of headache, dizziness, nausea and vomiting before dialysis; (3) the systolic pressure is greater than 200 mmHg patients before hemodialysis; (4) patients with cardiac grade III-IV; (5) irregular heart rhythm.;Exclusion criteria: (1) patients with cerebrovascular accident; (2) there were obvious symptoms of headache, dizziness, nausea and vomiting before dialysis; (3) the systolic pressure is greater than 200 mmHg patients before hemodialysis; (4) patients with cardiac grade III-IV; (5) irregular heart rhythm.;Exclusion criteria: (1) patients with cerebrovascular accident; (2) there were obvious symptoms of headache, dizziness, nausea and vomiting before dialysis; (3) the systolic pressure is greater than 200 mmHg patients before hemodialysis; (4) patients with cardiac grade III-IV; (5) irregular heart rhythm.

Design outcomes

Primary

MeasureTime frame
blood pressure variability;

Countries

China

Contacts

Public ContactXueyuan LIAO;Xueyuan LIAO;Xueyuan LIAO;Xueyuan LIAO;Xueyuan LIAO ;;;;

The Third Affiliated Hospital, Sun Yat-Sen University, Yuedong Hospital;The Third Affiliated Hospital, Sun Yat-Sen University, Yuedong Hospital;The Third Affiliated Hospital, Sun Yat-Sen University, Yuedong Hospital;The Third Affiliated Hospital, Sun Yat-Sen University, Yuedong Hospital;The Third Affiliated Hospital, Sun Yat-Sen University, Yuedong Hospital

1226468998@qq.com;1226468998@qq.com;1226468998@qq.com;1226468998@qq.com;1226468998@qq.com+86 13823884882;+86 13823884882;+86 13823884882;+86 13823884882;+86 13823884882

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026